DFVIX | VIHAX | DFVIX / VIHAX | |
Total Expense Ratio | 0.25 | 0.17 | 147% |
Annual Report Gross Expense Ratio | 0.45 | 0.17 | 265% |
Fund Existence | 31 years | 10 years | - |
Gain YTD | 33.138 | 25.865 | 128% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.23B | 13.4B | 24% |
Annual Yield % from dividends | 3.41 | 3.95 | 86% |
Returns for 1 year | 27.50 | 18.56 | 148% |
Returns for 3 years | 90.09 | 63.45 | 142% |
Returns for 5 years | 122.37 | 69.66 | 176% |
Returns for 10 years | 91.16 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFIX | 14.66 | 0.10 | +0.69% |
AlphaCentric Life Sciences & Hlthcare I | |||
EIVFX | 14.54 | 0.10 | +0.69% |
Allspring Special Large Cap Value R6 | |||
HWSAX | 73.27 | 0.17 | +0.23% |
Hotchkis & Wiley Small Cap Value A | |||
FADTX | 144.64 | N/A | N/A |
Fidelity Advisor Technology A | |||
EMECX | 13.04 | -0.06 | -0.46% |
Ashmore Emerging Markets Equity C |